Galveston, TX, United States of America

Jeffrey S Farroni


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey S. Farroni

Introduction

Jeffrey S. Farroni is a notable inventor based in Galveston, TX (US). He has made significant contributions to the field of medical technology, particularly in the area of drug therapy modulation through vagus nerve stimulation. His innovative approach aims to enhance the efficacy of pharmacotherapy for patients suffering from various medical disorders.

Latest Patents

Farroni holds a patent for a method titled "Modulation of drug effects by vagus nerve stimulation." This patent describes a method of treating a patient undergoing pharmacotherapy with a selected drug. The process involves administering the drug at a specific time and applying an electrical signal to the vagus nerve at a different time. This signal is designed to modulate the pharmacologic and pharmacokinetic properties of the drug within the patient's body. The vagus nerve stimulation (VNS) can be performed alongside primary VNS therapy, enhancing the overall treatment for the patient.

Career Highlights

Farroni is associated with Cyberonics, Inc., a company known for its pioneering work in neuromodulation therapies. His role at Cyberonics has allowed him to explore and develop innovative solutions that address complex medical challenges. With a focus on improving patient outcomes, Farroni's work exemplifies the intersection of technology and healthcare.

Collaborations

One of Farroni's notable collaborators is William R. Buras. Their partnership reflects a commitment to advancing medical technology and improving therapeutic strategies for patients.

Conclusion

Jeffrey S. Farroni's contributions to the field of medical technology through his patent on vagus nerve stimulation demonstrate his innovative spirit and dedication to enhancing patient care. His work continues to influence the landscape of pharmacotherapy and neuromodulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…